Presentation is loading. Please wait.

Presentation is loading. Please wait.

Ugo Pastorino, MD, Marc Buyse, ScD, Godehard Friedel, MD, Robert J

Published byPenelope Parker Modified over 6 years ago

Similar presentations

Presentation on theme: "Ugo Pastorino, MD, Marc Buyse, ScD, Godehard Friedel, MD, Robert J"— Presentation transcript:

1 Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases 
Ugo Pastorino, MD, Marc Buyse, ScD, Godehard Friedel, MD, Robert J. Ginsberg, MD, Philippe Girard, MD, Peter Goldstraw, MD, Michael Johnston, MD, Patricia McCormack, MD, Harvey Pass, MD, Joe B. Putnam, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 113, Issue 1, Pages (January 1997) DOI: /S (97) Copyright © 1997 Mosby, Inc. Terms and Conditions

2 Fig. 1 Overall actuarial survival after lung metastasectomy: complete resection versus incomplete resection. The number of patients at risk at 5, 10, and 15 years is reported at the bottom of the curve. The Journal of Thoracic and Cardiovascular Surgery  , 37-49DOI: ( /S (97) ) Copyright © 1997 Mosby, Inc. Terms and Conditions

3 Fig. 2 Survival of patients having complete resections according to the DFI: 0 to 11 months, 12 to 35 months, and 36 or more months. The Journal of Thoracic and Cardiovascular Surgery  , 37-49DOI: ( /S (97) ) Copyright © 1997 Mosby, Inc. Terms and Conditions

4 Fig. 3 Survival of patients having complete resections according to the number of pathologically proved metastases: single lesions, two to three lesions, and four or more lesions. The Journal of Thoracic and Cardiovascular Surgery  , 37-49DOI: ( /S (97) ) Copyright © 1997 Mosby, Inc. Terms and Conditions

5 Fig. 4 Survival of patients having complete resections according to the four major primary tumors types: epithelial, sarcoma, germ cell, and melanoma. The Journal of Thoracic and Cardiovascular Surgery  , 37-49DOI: ( /S (97) ) Copyright © 1997 Mosby, Inc. Terms and Conditions

6 Fig. 5 Survival of the four prognostic groups: resectable, no risk factors (DFI ≥ 36 months and single metastasis); resectable, one risk factor (DFI < 36 months or multiple metastases); resectable, two risk factors (DFI < 36 months and multiple metastases), and unresectable. Germ cell and Wilms' tumors were excluded. The Journal of Thoracic and Cardiovascular Surgery  , 37-49DOI: ( /S (97) ) Copyright © 1997 Mosby, Inc. Terms and Conditions

Download ppt "Ugo Pastorino, MD, Marc Buyse, ScD, Godehard Friedel, MD, Robert J"

Similar presentations

The additional hospital costs generated in the management of complications of pacemaker and defibrillator implantations T.Bruce Ferguson, MD, Candice Lilley.

The additional hospital costs generated in the management of complications of pacemaker and defibrillator implantations T.Bruce Ferguson, MD, Candice Lilley.
Improved survival with pulmonary metastasectomy: An analysis of 1720 patients with pulmonary metastatic melanoma  Rebecca P. Petersen, MD, MSc, Steven.

Improved survival with pulmonary metastasectomy: An analysis of 1720 patients with pulmonary metastatic melanoma  Rebecca P. Petersen, MD, MSc, Steven.
Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma  Hideyuki Imoto, MD, Toshihiro.

Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma  Hideyuki Imoto, MD, Toshihiro.
Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L
Histopathologic Prognostic Factors in Resected Colorectal Lung Metastases  Satoshi Shiono, MD, Genichiro Ishii, MD, Kanji Nagai, MD, Junji Yoshida, MD,

Histopathologic Prognostic Factors in Resected Colorectal Lung Metastases  Satoshi Shiono, MD, Genichiro Ishii, MD, Kanji Nagai, MD, Junji Yoshida, MD,
Primary non-Hodgkin’s lymphoma of the lung

Primary non-Hodgkin’s lymphoma of the lung
Characteristics and outcomes of secondary nodules identified on initial computed tomography scan for patients undergoing resection for primary non–small.

Characteristics and outcomes of secondary nodules identified on initial computed tomography scan for patients undergoing resection for primary non–small.
Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection  Morihito Okada,

Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection  Morihito Okada,
Pulmonary resection for metastases from hepatocellular carcinoma: Factors influencing prognosis  Takahito Nakagawa, MD, Toshiya Kamiyama, MD, Kazuaki.

Pulmonary resection for metastases from hepatocellular carcinoma: Factors influencing prognosis  Takahito Nakagawa, MD, Toshiya Kamiyama, MD, Kazuaki.
Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma  Giulio Melloni, MD, Claudio.

Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma  Giulio Melloni, MD, Claudio.
Surgical treatment of thoracoabdominal aortic aneurysms by simple crossclamping: Risk factors and late results  Marc A.A.M. Schepens, MD, Jo J.A.M. Defauw,

Surgical treatment of thoracoabdominal aortic aneurysms by simple crossclamping: Risk factors and late results  Marc A.A.M. Schepens, MD, Jo J.A.M. Defauw,
Survival after resection of synchronous non–small cell lung cancer

Survival after resection of synchronous non–small cell lung cancer
Tumors of the esophagogastric junction

Tumors of the esophagogastric junction
Risk Factors for Lymph Node Metastases and Prognosticators of Survival in Patients Undergoing Pulmonary Metastasectomy for Colorectal Cancer  Servet Bölükbas,

Risk Factors for Lymph Node Metastases and Prognosticators of Survival in Patients Undergoing Pulmonary Metastasectomy for Colorectal Cancer  Servet Bölükbas,
Robert J. Korst, MD, Michael E. Burt, MD, PhD 

Robert J. Korst, MD, Michael E. Burt, MD, PhD 
James L. Cox, MD, Niv Ad, MD, Terry Palazzo, RN, MS 

James L. Cox, MD, Niv Ad, MD, Terry Palazzo, RN, MS 
Nael Martini, MDa, Manjit S. Bains, MDa, Michael E

Nael Martini, MDa, Manjit S. Bains, MDa, Michael E
Factors predicting patterns of recurrence after resection of N1 non-small cell lung carcinoma  Timothy E Sawyer, MD, James A Bonner, MD, Perry M Gould,

Factors predicting patterns of recurrence after resection of N1 non-small cell lung carcinoma  Timothy E Sawyer, MD, James A Bonner, MD, Perry M Gould,
Lobe-specific extent of systematic lymph node dissection for non–small cell lung carcinomas according to a retrospective study of metastasis and prognosis 

Lobe-specific extent of systematic lymph node dissection for non–small cell lung carcinomas according to a retrospective study of metastasis and prognosis 
Iwao Takanami, MD, Ken Takeuchi, MD, Masatoshi Giga, MD 

Iwao Takanami, MD, Ken Takeuchi, MD, Masatoshi Giga, MD 

Similar presentations

Ads by Google